The prevalence and clinical outcomes of microangiopathic hemolytic anemia in patients with biopsy-proven renal thrombotic microangiopathy

Am J Hematol. 2022 Nov;97(11):E426-E429. doi: 10.1002/ajh.26705. Epub 2022 Sep 10.

Gauri Bhutani¹, Nelson Leung^{2

3}, Samar M Said⁴, Anthony M Valeri⁵, Brad C Astor^{1

6}, Mary E Fidler⁴, Mariam P Alexander⁴, Lynn D Cornell⁴, Samih H Nasr⁴

¹ Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
² Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA.
⁵ Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York City, New York, USA.
⁶ Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

No abstract available

Publication types